Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0001193125-26-100309 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-10 | 2026-03-06+ | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $21.87 | -9,526 | 70.3K | -12% | -$208.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | S | D | 3,508 | $22.67 | 66,820 | D | — | — | (F1) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |
| 2 | Common | Common Stock | 2026-03-06 | S | D | 6,018 | $21.40 | 70,328 | D | — | — |